Immunophenotyping of end-stage lung disease patients on the transplant waiting list
Circulating immune features distinguishing end-stage fibrotic from obstructive disease remain poorly characterized. We sought to define the peripheral immune landscape across these conditions relative to healthy individuals and to test whether it predicts outcome after transplantation. Whole blood from 134 lung transplant candidates and 53 healthy controls was analyzed by flow cytometry. Major immune populations and B-cell, T-cell, dendritic-cell, and regulatory T-cell (Treg) subsets were profiled by manual gating and with unsupervised FlowSOM/UMAP clustering as qualitative confirmation. In the 114 candidates who subsequently underwent, the baseline immune state was tested against chronic lung allograft dysfunction (CLAD)-free survival and overall survival by Cox proportional-hazards regression. Both diseases shared a signature of lymphoid contraction against a background of leukocytosis. Total leukocytes were increased in both (p < 0.0001) and higher in fibrosis than obstruction (p = 0.002). CD8⁺ T cells, including CD57⁺ and PD1⁺ populations, were expanded in both diseases (p < 0.0001), and Tregs (FoxP3⁺, CD39⁺, CD45RA⁻) were enriched in both obstruction and fibrosis (p < 0.0001). Fibrosis was distinguished by a more pronounced CD4⁺ contraction and by selective enrichment of Helios⁺ Tregs and CD8⁺CD57⁺populations. This pre-transplant immune state did not predict CLAD-free or overall survival. End-stage lung disease is marked by a convergent reprogramming of peripheral immunity.
Authors
- Hatice Oya Berezhinskiy (ORCID: https://orcid.org/0009-0009-6037-5617)
- Sophia Auner (ORCID: https://orcid.org/0000-0003-0961-0182)
- Alberto Benazzo (ORCID: https://orcid.org/0000-0002-3549-4720)
- Péter Jaksch (ORCID: https://orcid.org/0000-0003-4635-3242)
- Ara Cho (ORCID: https://orcid.org/0000-0002-5555-2270)
- Konrad Hoetzenecker (ORCID: https://orcid.org/0000-0001-6775-7460)
- Thomas Wekerle (ORCID: https://orcid.org/0000-0001-5159-2796)
- Andreas Spittler (ORCID: https://orcid.org/0000-0003-2657-6836)
- Clemens Aigner (ORCID: https://orcid.org/0000-0002-7787-991X)
- Sophia Alemanno
- Marijo Jevtić
- Shahrooz Nasrollahi Shirazi
Institutions
- Comprehensive Cancer Center Vienna (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1038/s41598-026-80388-2
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Austrian Science Fund